BEL Pharmaceuticals & Biotechnology Net Return (BEPB)

Add to/Remove from a Portfolio  
2,356.37 +36.96    +1.59%
30/11 - Closed. Currency in EUR ( Disclaimer )
Type: Index
Market: Belgium
# Components: 8

  • Volume: -
  • Open: 2,319.22
  • Day's Range: 2,311.37 - 2,356.58
Start Trading
Pharmaceuticals & Biotechnology NR 2,356.37 +36.96 +1.59%
Add to/Remove from a Portfolio  

Pharmaceuticals & Biotechnology NR Overview

Prev. Close2,319.41
Day's Range2,311.37 - 2,356.58
Average Vol. (3m)-
52 wk Range1697.13 - 2356.37
1-Year Return37.5%

BEL Pharmaceuticals & Biotechnology Net Return News & Analysis

Related Articles

Most Active Stocks

  Name Last Prev. High Low Chg. % Vol. Time
UCB 84.52 84.52 84.52 82.74 +1.70% 725.29K 30/11  
Ablynx NV 14.095 14.095 14.095 13.870 +2.14% 216.17K 30/11  
Tigenix NV 0.9760 0.9760 0.9900 0.9610 +0.51% 208.79K 30/11  
Galapagos 47.210 47.210 47.490 46.515 +1.31% 94.11K 30/11  
Mdxhealth 3.769 3.769 3.810 3.769 -0.82% 50.72K 30/11  
Thrombogenics 3.610 3.610 3.777 3.610 -2.96% 47.28K 30/11  
Celyad 44.98 44.98 45.25 43.71 +0.74% 36.01K 30/11  
Tubize-Fin 69.500 69.500 69.500 67.060 +1.62% 14.68K 30/11  

Top Gainers

Name Last Chg. Chg. %
Ablynx NV 14.095 +0.295 +2.14%
UCB 84.52 +1.41 +1.70%
Tubize-Fin 69.500 +1.110 +1.62%
Galapagos 47.210 +0.610 +1.31%
Celyad 44.98 +0.33 +0.74%

Top Losers

Name Last Chg. Chg. %
Thrombogenics 3.610 -0.110 -2.96%
Mdxhealth 3.769 -0.031 -0.82%
Tigenix NV 0.9760 +0.0050 +0.51%
Celyad 44.98 +0.33 +0.74%
Galapagos 47.210 +0.610 +1.31%

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit  
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Services Agency (Japan), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong) $250 Apply

My Sentiments

Add your sentiment:
Members' Sentiments:

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Add Chart to Comment
BEL Pharmaceuticals & Biotechnology
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Post 1000
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Post 1000
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.